Lancet study warns against the one-size fits all approach

But it’s important to get the dose just right, say experts

The risk of internal bleeding is far higher than previously thought

Lab studies point to platelet action as key to anti-tumour effect

Its makers say it helps doctors apply recommendations in clinical guidelines

But the good starts outweighing the harm after the age of 65, according to the results of large, long-term trial